PD-L1 expression, while conventionally associated with immune suppression, occasionally demonstrates favorable prognostic value, underscoring a nuanced immunobiological interplay influenced by tumor context and checkpoint saturation [16,17,18]. This evidence concerns the gene CD274 and neoplasm.